21 "Inflammatory bowel diseases" clinical trials found.
-
VEDOKIDS study: Predicting response to Vedolizumab in Pediatric Inflammatory Bowel Diseases including drug levels: a multi-center prospective Pan- European cohort study (P-ECCO and ESPGHAN)
The purpose of this research study is to learn more about a medication used to treat crohns and ulcerative colitis. Subjects are invited to participate ...Phase N/A
Interventional
-
TARGET-IBD: A 5-year longitudinal observational study of patients undergoing therapy for inflammatory bowel disease (IBD)
This study is looking to enroll patients with inflammatory bowel disease (IBD), which may include Crohn's disease (CD), ulcerative colitis (UC) and Indeterminate Colitis ... -
Managing Infliximab Reinduction After temporary Discontinuation of Drug
The purpose of this study is to determine what is the best schedule for restarting infliximab (also known as Remicade) in patients with inflammatory bowel ... -
Corrona Inflammatory Bowel Disease (IBD) Registry
The purpose of this registry study is to learn more about Inflammatory Bowel Disease (IBD), how doctors treat IBD, how well medications and other treatments ... -
The PRECIOUS Study: Predicting Crohn's & Colitis Outcomes in the United States
The purpose of this study is to evaluate a test called PredictSURE IBD™ in the US population. PredictSURE IBD™ is a “prognostic” blood test administered ... -
AbbVie Inc. Study M16-006
The purpose of this study is to evaluate the efficacy and safety of different doses of risankizumab and determine how well it works in managing ...Phase
Interventional
-
M14-431 A Multicenter Randomized Double-Blind Placebo-Controlled Induction Study of the Efficacy and Safety of Upadacitinib (ABT 494) in Subject's with Moderately to Severely Active Crohn's Disease who have Inadequately Responded to or are Intolerant t
The purpose of this study is to evaluate the safety of upadacitinib and determine how well it works, as well as the pharmacokinetics (PK) (how ...Phase
Interventional
-
A Multicenter Randomized Double-Blind Placebo-Controlled 52-Week Maintenance and an Open-Label Extension Study of the Efficacy and Safety of Risankizumab in Subjects with Crohn's Disease Who Responded to Induction Treatment in M16-006 or M15-991
The study consists of 3 sub-studies: This study is looking to evaluate the efficacy and safety of risankizumab versus placebo as maintenance therapy in subjects ...Phase
Interventional
-
Combined Phase 3 Double-blind Randomized Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn's Disease
The primary objectives of this study are to evaluate the safety and efficacy of filgotinib during induction and maintenance treatment of moderately to severely active ...Phase
Interventional
-
A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Crohn's Disease
The primary objective of this study is to observe the long-term safety of filgotinib in subjects who have completed or met protocol specified efficacy discontinuation ...Phase
Interventional
